Deardorf Caren 4
4 · Magenta Therapeutics, Inc. · Filed Jul 8, 2021
Insider Transaction Report
Form 4
Deardorf Caren
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-06+200,000→ 200,000 totalExercise: $9.41Exp: 2031-07-05→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exerciseable over four years, with 25% of this option vesting on July 6, 2022, and the remainder vesting in 36 equal monthly installments thereafter.